Melanoma Clinical Trials in Florida

Showing 81-96 of 96 trials

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

NCT00110994

This is a randomized, double blind, placebo controlled, multicenter, phase II study to compare the anti-tumor activity as measured by progression-free survival (PFS) and the tolerability of Sorafenib in combination with Dacarbazine (DTIC) versus DTIC in combination with placebo in subjects with unresectable Stage III or Stage IV melanoma who have not received prior cytotoxic chemotherapy. A total of approximately 98 subjects will be randomized to receive DTIC + Sorafenib or DTIC + Placebo.

CancerMelanoma

Bayer101 participantsStarted Apr 2005

Tucson, Arizona, United States • Aurora, Colorado, United States • Lakeland, Florida, United States +11 more locations

UNKNOWNPHASE225 miles

Vaccine Therapy in Treating Patients With Malignant Melanoma

NCT00128583

RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with malignant melanoma.

Melanoma (Skin)

CancerVax CorporationStarted Jul 2005

Palm Springs, California, United States • Santa Monica, California, United States • Lakeland, Florida, United States +8 more locations

PreviousPage 5 of 5

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Melanoma Trials in Other Cities

Vaccine Therapy for Patients With Stage IV Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

CP-675,206 In Patients With Advanced Melanoma

Study of XL281 in Adults With Solid Tumors

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Study of CP-675,206 in Refractory Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Other Conditions in Florida